Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    12578439 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Placebo;   Drug: OROS (methylphenidate HCl);   Drug: Ritalin (methylphenidate)

Indicates status has not been verified in more than two years